Artesunate
Top View
- Overview of Current Application of Artemisinin Derivatives for Malaria Control
- Drugs for Parasitic Infections (2013 Edition)
- Guideline WHO Guidelines for Malaria
- Antiprotozoal Compounds: State of the Art and New Developments F
- Expanded Access IND Protocol: Use of Intravenous Artesunate for Treatment of Severe Malaria in the United States
- The Therapeutic Effect of Artesunate on Rosacea Through the Inhibition of the JAK/STAT Signaling Pathway
- Combination Anti-Malarial Therapy and WHO Recommendations
- WHO Guidance for Prevention and Treatment of Malaria in Pregnancy
- Montefiore Malaria Treatment Guideline for Adults (Adapted from July 2013 CDC Guidelines & 2019 Update)
- Pharmaceutical Composition Comprising Artesunate, Sulfamethoxypyrazine and Pyrimethamine for Use in the Treatment of Malaria
- The Role of Natural Products in Drug Discovery and Development Against Neglected Tropical Diseases
- The Cardiotoxicity of Antimalarials
- Guidelines for the Treatment of Malaria in Malawi
- Artesunate, Such As Anaphylaxis
- (12) United States Patent (10) Patent No.: US 7,566.465 B2 Kubata Et Al
- Guidelines for the Treatment of Malaria
- Protocol for Compassionate Use of Intravenous Artesunate For
- Protocol for Compassionate Use of Intravenous Artesunate for Severe Malaria